TruScreen Group Ltd Sustainability Reports
TruScreen Group Limited develops, manufactures, and distributes an AI-enabled medical device designed for real-time cervical cancer screening. The system uses opto-electrical technology to detect pre-cancerous and cancerous tissue on the cervix without requiring biological tissue samples.
Sector: Manufacturing
Country: New Zealand
Exchange: New Zealand Exchange (NZX)
FIGI: BBG007HRDYP0
10 reports from 2017 to 2026
